CONTACT

Rebaudioside M

SWEETNESS

WHAT IT IS

Rebaudioside M, usually shortened to Reb-M, is a sweet-tasting member of the steviol-glycoside family. Naming it precisely distinguishes the selected compound from the broader label stevia.

WHY IT'S HERE

Reb-M provides intense sweetness in small quantities, helping balance sourness and make a drink more enjoyable without the bulk of sugar. Its role is sensory: a sweet finishing note that rounds out the overall taste.

THE SHORT VERSION

Adds sweetness to help balance tart or bitter tastes.

From the current OVERT ingredient guide. Ingredient reference information; check the current product label for inclusion, amounts, directions and warnings. Research on an ingredient does not establish the effects of a finished OVERT formula.

Read the original guide and references ↗
Rebaudioside M — original OVERT ingredient guide page
Research context and selected references
Reb-M identifies a specific steviol glycoside. Commercial preparations can use different production routes, and the name does not alone prove leaf extraction or a particular purity. These references concern sweetness and ingredient identity, without a recovery or metabolic claim.
  1. OFFICIAL SWEETENER EVIDENCE AND IDENTITY OVERVIEW

    U.S. Food and Drug Administration. Aspartame and Other Sweeteners in Food: steviol glycosides and plant-based sweeteners.

    Explains high-intensity sweeteners, including purified steviol glycosides and different production approaches. It supports distinguishing a specified glycoside from the broad word stevia, without establishing the identity or purity of an undisclosed supplier's particular preparation.

    Read publication ↗ (Read source: fda.gov)

  2. OFFICIAL PREPARATION-SPECIFIC GRAS RECORD

    U.S. Food and Drug Administration. GRAS Notice 1260: Rebaudioside M produced by enzymatic treatment of steviol glycosides. Inventory record and agency response, 2025.

    Records an enzyme-produced Reb-M preparation and its intended sweetener use. It illustrates why production route is a separate specification; the notice does not establish that OVERT uses this grade or provide evidence of a clinical benefit.

    Read publication ↗ (Read source: hfpappexternal.fda.gov)

RESEARCH IN CONTEXT Ingredient studies do not establish the effects of the finished OVERT formulas. Forms, doses and study populations may differ. Technical sources describe identity or function. Source links are clickable in the digital guide. 104
Open source page 104 in the guide ↗

Contact OVERT

Questions about our products or ingredients?

Customer care

Explore the research

Understand the ingredients and the context behind them.

The ingredient library

The complete guide

The art and science of modern wellness, in detail.

Read the guidebook